For (9)
Blair Hamilton, Andrew Brown et al. · 86 citations
Cross-sectional laboratory study of 23 transgender women, 21 cisgender women, and cisgender men athletes found transgender women had similar handgrip strength, lower-body power, and aerobic capacity to cisgender women, suggesting performance variation depends on specific sport and physiological measures rather than categorical differences.
Joanna Harper, Emma O'Donnell et al.
Systematic review finding that hormone therapy reduces strength/lean mass and rapidly lowers haemoglobin toward cisgender female ranges, supporting sport-specific, evidence-based inclusion policies while acknowledging remaining uncertainties.
Ada S Cheung, Sav Zwickl et al.
A comprehensive narrative review examining how gender-affirming hormone therapy impacts physical performance, muscle strength, and endurance markers in transgender individuals, finding that existing evidence comprises primarily small studies, with findings suggesting performance changes correlate with hormone therapy duration and type.
ATHIWAT SAITONG, WITTHAWAT NAEOWONG et al.
Cross-sectional study comparing physical fitness measures of transgender women (n=30) on long-term feminizing hormone therapy (8-10 years) with reference cisgender women and men. Found transgender women demonstrated similar levels of physical fitness to cisgender women, with significantly lower performance than cisgender men across measures including muscular strength, anaerobic power, and aerobic capacity.
Laura Cuadrado Clemente, María Miguélez González et al.
Comprehensive endocrinology literature review examining gender-affirming hormone therapy's impact on athletic performance. Found significant decreases in hematocrit, total serum testosterone, lean body mass, strength, and muscle area after 12 months of GAHT, with increases in fat mass, supporting inclusion policies with appropriate hormone suppression criteria.
Joanna Harper, Richard C. Blagrove et al.
This study evaluated athletic performance in 9 transgender women runners and 1 swimmer using both retrospective and prospective data. Results showed that average race times for runners increased by 14.6% after ~31 months of GAHT, with performance adjustments accounting for training differences. The findings suggest that event demands and exercise training significantly affect the impact of hormone therapy on athletic performance.
Sofia Mendes Sieczkowska, Bruna Caruso Mazzolani et al.
Systematic review/meta-analysis reporting that, after gender-affirming hormone therapy, transgender women show comparable physical fitness measures to cisgender women on several outcomes, while noting evidence gaps in elite sport.
Mathy and Mirreghabie argue against exclusion of transgender athletes based on testosterone levels, examining sex and gender as social constructs and reviewing demographic changes in the transgender population since 2014. The paper emphasizes that restricting transgender participation may exacerbate health disparities in this marginalized population.